UBS’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$159K Buy
3,290
+452
+16% +$22.1K ﹤0.01% 5437
2014
Q2
$129K Sell
2,838
-2,845
-50% -$125K ﹤0.01% 5644
2014
Q1
$257K Sell
5,683
-631
-10% -$31.1K ﹤0.01% 4927
2013
Q4
$299K Buy
6,314
+79
+1% +$3.43K ﹤0.01% 4853
2013
Q3
$246K Buy
6,235
+2,235
+56% +$83K ﹤0.01% 4923
2013
Q2
$132K Buy
+4,000
New +$130K ﹤0.01% 5552

Other funds holding ACHC

UBS's ACHC Position: Q3 2014 in Review

UBS increased its Acadia Healthcare (ACHC) stake by 16% in Q3 2014, buying an estimated $22.1K and bringing the position to 3,290 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #5437.

UBS first reported a position in ACHC in Q2 2013 and has held it in 6 quarters since. The position peaked at $299K in Q4 2013. 175 funds tracked by Wall St. Rank hold ACHC as of Q3 2014.

  • UBS held 3,290 shares of Acadia Healthcare worth $159K as of Q3 2014.
  • UBS bought 452 Acadia Healthcare shares in Q3 2014, an estimated $22.1K.
  • Acadia Healthcare made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5437 holding.
  • UBS first reported a position in Acadia Healthcare in Q2 2013 and has held it in 6 quarters since.
  • UBS's Acadia Healthcare position peaked at $299K in Q4 2013.
  • 175 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.